Efficacy, tolerability, quality of life and spasticity in outpatients with remitting multiple sclerosis (RMS) treated with glatiramer acetate (GA) - Results of an observational study
Neurological Disorders and Therapeutics · 2018
DOI: 10.15761/ndt.1000129 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurological Disorders and Therapeutics, 2018. Verfasst von Haupts M und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
M, H., M, K., & U, F. (2018). Efficacy, tolerability, quality of life and spasticity in outpatients with remitting multiple sclerosis (RMS) treated with glatiramer acetate (GA) - Results of an observational study. Neurological Disorders and Therapeutics. https://doi.org/10.15761/ndt.1000129
Vancouver
M H, M K, U F. Efficacy, tolerability, quality of life and spasticity in outpatients with remitting multiple sclerosis (RMS) treated with glatiramer acetate (GA) - Results of an observational study. Neurological Disorders and Therapeutics. 2018. doi:10.15761/ndt.1000129
BibTeX
@article{M2018,
author = {M, Haupts and M, Klasser and U, Faude},
title = {Efficacy, tolerability, quality of life and spasticity in outpatients with remitting multiple sclerosis (RMS) treated with glatiramer acetate (GA) - Results of an observational study},
journal = {Neurological Disorders and Therapeutics},
year = {2018},
doi = {10.15761/ndt.1000129}
}
EUVIMED